Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 17, 2020
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
Konstantinos Aprilakis Upgraded (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020
Konstantinos Aprilakis of Deutsche Bank, Upgraded "Blueprint Medicines Corporation" (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020.
Konstantinos has made no other calls on BPMC in the last 4 months.
There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Konstantinos's Rating of Hold.
This is the rating of the analyst that currently disagrees with Konstantinos
- Andrew Berens of "Morgan Stanley" Maintained at Buy with Decreased Target to $103 on, Tuesday, February 18th, 2020
Similar Stocks and Investing Articles
[ Thu, Mar 05th 2020
] - WOPRAI
[ Mon, Mar 02nd 2020
] - WOPRAI
[ Mon, Mar 02nd 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Jan 28th 2020
] - WOPRAI
[ Tue, Dec 10th 2019
] - WOPRAI
[ Wed, Nov 06th 2019
] - WOPRAI
[ Tue, Oct 29th 2019
] - WOPRAI
[ Fri, Oct 11th 2019
] - WOPRAI
[ Mon, Apr 02nd 2018
] - WOPRAI